---
figid: PMC5306250__fphar-08-00043-g0010
figlink: /pmc/articles/PMC5306250/figure/F10/
number: F10
caption: The proposed working pathway for ginsenoside Rg5 action in hypoxic adipose
  tissue. Saturated fatty acid PA induces hypoxia with ER stress in adipose tissue,
  and then increases succinate formation. Succinate promotes IL-1β production through
  NLRP3 inflammasome activation, and then induces cAMP/PKA signaling by inactivation
  of PDE3B, leading to lipolysis. PA also decreases AMP concentration, and then increases
  cAMP accumulation. The release of FFAs increases cytosolic DAG, PKC translocation,
  ceramide accumulation and inhibits insulin-mediated Akt phosphorylation, thus leading
  to insulin resistance in muscle. Rg5 inhibits lipolysis by suppression of succinate
  accumulation in hypoxic adipocytes and thus prevents insulin resistance in muscle.
pmcid: PMC5306250
papertitle: Ginsenoside Rg5 Inhibits Succinate-Associated Lipolysis in Adipose Tissue
  and Prevents Muscle Insulin Resistance.
reftext: Na Xiao, et al. Front Pharmacol. 2017;8:43.
pmc_ranked_result_index: '106145'
pathway_score: 0.949073
filename: fphar-08-00043-g0010.jpg
figtitle: Proposed working pathway for ginsenoside Rg5 action in hypoxic adipose tissue
year: '2017'
organisms: Homo sapiens
ndex: 8977cb42-def3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5306250__fphar-08-00043-g0010.html
  '@type': Dataset
  description: The proposed working pathway for ginsenoside Rg5 action in hypoxic
    adipose tissue. Saturated fatty acid PA induces hypoxia with ER stress in adipose
    tissue, and then increases succinate formation. Succinate promotes IL-1β production
    through NLRP3 inflammasome activation, and then induces cAMP/PKA signaling by
    inactivation of PDE3B, leading to lipolysis. PA also decreases AMP concentration,
    and then increases cAMP accumulation. The release of FFAs increases cytosolic
    DAG, PKC translocation, ceramide accumulation and inhibits insulin-mediated Akt
    phosphorylation, thus leading to insulin resistance in muscle. Rg5 inhibits lipolysis
    by suppression of succinate accumulation in hypoxic adipocytes and thus prevents
    insulin resistance in muscle.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MFAP1
  - IRS4
  - AKT3
  - AKT2
  - IRS1
  - NLRP3
  - PRKACA
  - AKT1
  - IL18
  - PRKACB
  - PRKAR2A
  - PRKAR2B
  - IRS2
  - PRKAR1A
  - PRKAR1B
  - PRKACG
  - PDE3B
  - Ceramide
genes:
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: CAMP/PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: CAMP/PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: CAMP/PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: CAMP/PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: CAMP/PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: CAMP/PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: CAMP/PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PDE3B
  symbol: PDE3B
  source: hgnc_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
chemicals:
- word: Ceramide
  source: MESH
  identifier: D002518
diseases: []
figid_alias: PMC5306250__F10
redirect_from: /figures/PMC5306250__F10
figtype: Figure
---
